Sunday, May 10, 2020

FDA authorizes rapid COVID 19 antigen test

FDA authorizes rapid COVID 19 antigen test
..

The Foodstuff as well as Pharmaceutic Direction has granted the original emergency use fiat to dissecting healthcare congregation Quidel Corp. for the original COVID-19 antigen test, the bureau announced. Antigen tests can quickly sniff the coronavirus, however are haphazardly considered less pure than other types of tests that search out the virus.

Antigen tests for COVID-19 are coequal to rapid-fire flu or strep tests. This therapy can be run in a lab or in a doctor's office, as well as personalized takes hazardous 15 minutes.

The tests typically used to diagnosticate COVID-19, chosen PCR tests, search out the matriclinous subsequence of the coronavirus in a waxer domesticated from a patient's nose or throat. Antigen tests, on the other hand, squint for molecules on the tralucent of the virus. They revealment results numerous increasingly quickly, however are less accurate. If the therapy says a uncomplaining sample is positive, it's permitted to be correct. However Quidel's therapy has a upper span of misrepresentative negatives: it personalized correctly identifies uncomplaining samples that contains the coronavirus 85 percent of the time, the company's curvation controlling told the Wall Street Journal.

The FDA says privative results from an antigen therapy should be confirmed with a PCR test.

Quidel's CEO told the WSJ the congregation is ramping up mass-production to increase production of the test, officially chosen the Sofia 2 SARS Antigen FIA, with a goal of validness 1 mimic per week.

No comments:

Post a Comment